SG11201906731XA - Media and methods for enhancing the survival and proliferation of stem cells - Google Patents
Media and methods for enhancing the survival and proliferation of stem cellsInfo
- Publication number
- SG11201906731XA SG11201906731XA SG11201906731XA SG11201906731XA SG11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA
- Authority
- SG
- Singapore
- Prior art keywords
- vancouver
- suite
- international
- british columbia
- street
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 5
- 230000035755 proliferation Effects 0.000 title abstract 4
- 230000004083 survival effect Effects 0.000 title abstract 4
- 230000002708 enhancing effect Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 150000002632 lipids Chemical class 0.000 abstract 4
- 239000001963 growth medium Substances 0.000 abstract 3
- 239000013589 supplement Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 241001486234 Sciota Species 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762449413P | 2017-01-23 | 2017-01-23 | |
| US201762518776P | 2017-06-13 | 2017-06-13 | |
| US201762608875P | 2017-12-21 | 2017-12-21 | |
| PCT/CA2018/050076 WO2018132926A1 (en) | 2017-01-23 | 2018-01-23 | Media and methods for enhancing the survival and proliferation of stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201906731XA true SG11201906731XA (en) | 2019-08-27 |
Family
ID=62907538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201906731XA SG11201906731XA (en) | 2017-01-23 | 2018-01-23 | Media and methods for enhancing the survival and proliferation of stem cells |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11697796B2 (https=) |
| EP (2) | EP4361256A3 (https=) |
| JP (1) | JP7049347B2 (https=) |
| CN (1) | CN110462025B (https=) |
| AU (1) | AU2018209127B2 (https=) |
| CA (1) | CA3051141C (https=) |
| IL (1) | IL268194B (https=) |
| SG (1) | SG11201906731XA (https=) |
| WO (1) | WO2018132926A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201906731XA (en) | 2017-01-23 | 2019-08-27 | Stemcell Technologies Canada Inc | Media and methods for enhancing the survival and proliferation of stem cells |
| CN111808797A (zh) * | 2020-07-28 | 2020-10-23 | 湖南赛诺生物科技股份有限公司 | Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂 |
| JP2022032793A (ja) * | 2020-08-14 | 2022-02-25 | アルブキュラ コーポレーション | アルブミン組成物並びにそれを製造及び使用する方法 |
| CA3191071A1 (en) | 2020-09-02 | 2022-03-10 | Yaacov Guy | Cellular composition for treatment of diseases, disorders or conditions and method of use |
| WO2022114724A1 (ko) * | 2020-11-27 | 2022-06-02 | (주)엑셀세라퓨틱스 | 고효율 및 고순도 엑소좀 생산용 배지 조성물 |
| US20240117313A1 (en) * | 2021-02-15 | 2024-04-11 | Toppan Inc. | Method for producing three-dimensional tissue body and method for promoting differentiation of adipose-derived stem cells |
| CN116121186A (zh) * | 2023-01-03 | 2023-05-16 | 内蒙古奥普赛生物科技有限公司 | 一种利用棕榈油酸培养脂肪间充质干细胞的方法 |
| EP4698630A1 (en) * | 2023-04-20 | 2026-02-25 | Stemcell Technologies Canada Inc. | Methods for large scale expansion of pluripotent stem cells (pscs) |
| CN116814532B (zh) * | 2023-07-10 | 2025-02-11 | 上海迈邦生物科技有限公司 | 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2277278A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| CN101052712A (zh) * | 2004-09-08 | 2007-10-10 | 威斯康星校友研究基金会 | 培养人胚胎干细胞 |
| JP4385076B2 (ja) * | 2006-01-13 | 2009-12-16 | 独立行政法人科学技術振興機構 | 動物細胞を無血清培養するための培地用添加剤、キット及びこれらの利用 |
| US8241908B2 (en) * | 2006-05-16 | 2012-08-14 | Becton, Dickinson And Company | Extracellular matrix coated surface for culturing cells |
| GB0613756D0 (en) | 2006-07-12 | 2006-08-23 | Univ Sheffield | Cell culture medium |
| ES2360782B1 (es) | 2009-07-28 | 2012-03-12 | Grifols, S.A. | Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos. |
| FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| US10323919B2 (en) | 2010-01-06 | 2019-06-18 | Ervin Industries, Inc. | Frangible, ceramic-metal composite objects and methods of making the same |
| JP6148429B2 (ja) | 2011-01-31 | 2017-06-14 | 協和発酵バイオ株式会社 | ヒト多能性幹細胞の培養方法 |
| US8497124B2 (en) * | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| HK1206058A1 (en) | 2012-03-07 | 2015-12-31 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| JP2016521971A (ja) * | 2013-04-23 | 2016-07-28 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッド | 単離ナイーブ型多能性幹細胞およびそれを発生させる方法関連出願本出願は、米国特許法１１９条第（ｅ）項に基づき、２０１４年１月２９日出願の米国特許仮出願第６１／９３２，９３５号、２０１３年９月１７日出願の米国特許仮出願第６１／８７８，７６９号、および２０１３年４月２３日出願の米国特許仮出願第６１／８１４，９２０号の優先権を主張する。また、本出願は、同時に提出された同出願人による同時係属出願である、ＹａｑｕｂＨＡＮＮＡ、ＮｏａＮＯＶＥＲＳＨＴＥＲＮ、およびＹｏａｃｈＲＡＩＳによる米国特許出願（発明の名称「単離ナイーブ型多能性幹細胞およびそれを発生させる方法（ＩＳＯＬＡＴＥＤＮＡＩＶＥＰＬＵＲＩＰＯＴＥＮＴＳＴＥＭＣＥＬＬＳＡＮＤＭＥＴＨＯＤＳＯＦＧＥＮＥＲＡＴＩＮＧＳＡＭＥ）」）（代理人事件記録簿第５８８７０号）にも関する。上記出願の内容はその全体を参考として本明細書に組み込む。 |
| CN105283541B (zh) * | 2013-05-30 | 2019-02-19 | 味之素株式会社 | 干细胞培养用培养基 |
| WO2015042356A1 (en) | 2013-09-19 | 2015-03-26 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chemically defined culture medium for stem cell maintenance and differentiation |
| EP3279318A4 (en) * | 2015-03-30 | 2018-08-29 | Ajinomoto Co., Inc. | Human serum albumin-containing culture medium for growth of neural stem cells |
| SG11201906731XA (en) | 2017-01-23 | 2019-08-27 | Stemcell Technologies Canada Inc | Media and methods for enhancing the survival and proliferation of stem cells |
-
2018
- 2018-01-23 SG SG11201906731XA patent/SG11201906731XA/en unknown
- 2018-01-23 US US16/480,025 patent/US11697796B2/en active Active
- 2018-01-23 EP EP24162728.0A patent/EP4361256A3/en active Pending
- 2018-01-23 CN CN201880019192.7A patent/CN110462025B/zh active Active
- 2018-01-23 CA CA3051141A patent/CA3051141C/en active Active
- 2018-01-23 JP JP2019539835A patent/JP7049347B2/ja active Active
- 2018-01-23 AU AU2018209127A patent/AU2018209127B2/en active Active
- 2018-01-23 WO PCT/CA2018/050076 patent/WO2018132926A1/en not_active Ceased
- 2018-01-23 EP EP18741389.3A patent/EP3571290B1/en active Active
-
2019
- 2019-07-21 IL IL268194A patent/IL268194B/en unknown
-
2023
- 2023-03-15 US US18/184,517 patent/US20230250392A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110462025B (zh) | 2023-11-21 |
| JP2020505038A (ja) | 2020-02-20 |
| IL268194A (en) | 2019-09-26 |
| EP4361256A2 (en) | 2024-05-01 |
| IL268194B (en) | 2022-05-01 |
| CA3051141C (en) | 2021-06-22 |
| CA3051141A1 (en) | 2018-07-26 |
| JP7049347B2 (ja) | 2022-04-06 |
| US20200017825A1 (en) | 2020-01-16 |
| US11697796B2 (en) | 2023-07-11 |
| EP4361256A3 (en) | 2024-07-31 |
| EP3571290A1 (en) | 2019-11-27 |
| WO2018132926A1 (en) | 2018-07-26 |
| AU2018209127A1 (en) | 2019-08-08 |
| US20230250392A1 (en) | 2023-08-10 |
| EP3571290B1 (en) | 2024-04-10 |
| CN110462025A (zh) | 2019-11-15 |
| AU2018209127B2 (en) | 2021-10-21 |
| EP3571290A4 (en) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201906731XA (en) | Media and methods for enhancing the survival and proliferation of stem cells | |
| SG11201804375WA (en) | Compositions and methods for internalizing enzymes | |
| SG11201909710XA (en) | Indole ahr inhibitors and uses thereof | |
| SG11201909541WA (en) | Chimeric antibody/t-cell receptor constructs and uses thereof | |
| SG11201406903SA (en) | Cell culture compositions and methods for polypeptide production | |
| SG11201806398YA (en) | Optimized factor viii genes | |
| SG11201906883SA (en) | Methods for the administration of certain vmat2 inhibitors | |
| SG11201808783XA (en) | Cd80 variant immunomodulatory proteins and uses thereof | |
| SG11201909931PA (en) | Oligomeric particle reagents and methods of use thereof | |
| SG11201907769XA (en) | Cd80 variant immunomodulatory proteins and uses thereof | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201808799SA (en) | Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors | |
| SG11201807401RA (en) | Therapeutic membrane vesicles | |
| SG11201809710RA (en) | Genetically engineered cells and methods of making the same | |
| SG11201806650VA (en) | Systems and methods for providing a personal distributed ledger | |
| SG11201807187XA (en) | Binding members to pd-l1 | |
| SG11201807608VA (en) | Dynamically convey information of demodulation reference signal and phase noise compensation reference signal | |
| SG11201407417VA (en) | Encoding and reconstruction of residual data based on support information | |
| SG11201909419XA (en) | Hydrogel for cell culture and biomedical applications | |
| SG11201900231RA (en) | Culture media for culturing pluripotent stem cells in suspension | |
| SG11201900609PA (en) | Method and system for providing buffer solutions | |
| SG11201906238TA (en) | Split sector level sweep using beamforming refinement frames | |
| SG11201408536WA (en) | METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF | |
| SG11201900058YA (en) | Method of generating mesenchymal stem cells and uses thereof | |
| SG11201408163VA (en) | Modified fibronectin fragments or variants and uses thereof |